Biden signs bipartisan bill banning Russian uranium imports

President Biden on Monday evening signed a bipartisan bill prohibiting Russian imports of enriched uranium, the main fuel used by nuclear power plants, a move intended to cut off one of the last significant flows of money from the United States to Russia amid the war in Ukraine.

Congress took swift action to ban Russian oil and gas imports a month after the February 2022 invasion of Ukraine. But sanctions on uranium imports have taken much longer, in part because Russia supplies roughly 20 percent of U.S. nuclear fuel, leading some lawmakers to fear disruptions to the nation’s 93 nuclear reactors.

Source link

Related Posts

Mastercard stock hits all-time high at $537.18 amid robust growth

In other recent news, Mastercard has announced a new share repurchase program, allowing the company to buy back up to $12 billion of its Class A shares. This program is…

Read more

AIRE stock touches 52-week high at $2.3 amid market fluctuations

In other recent news, reAlpha Tech Corp. has made significant strides in its operations. The company announced the launch of reAlpha Enterprise, an AI-driven homebuying platform tailored for corporate relocation…

Read more

Lebanon hopes for neighbourly relations in first message to new Syria government

Lebanese Foreign Minister Abdallah Bou Habib passed on the message – Beirut’s first to the new administration in Damascus – to his Syrian counterpart Asaad Hassan al-Shibani in a phone…

Read more

Byrna Technologies Stock Hits 52-Week High at $30.15 Amid Surge

In other recent news, Byrna Technologies Inc. has reported substantial growth in its fiscal third quarter 2024 earnings. The company announced a 194% year-over-year increase in net revenue, reaching $20.9…

Read more

Wall Street slips as rising yields pressure some shares

(Reuters) -Wall Street’s main indexes were subdued in light trading volumes on Thursday, as rising yields limited gains in equities, while investors looked for a year-end boost from the so-called…

Read more

LVTX stock touches 52-week low at $0.95 amid market challenges

In other recent news, Lava Therapeutics has experienced significant changes in its financial and clinical projections. The company decided to halt its LAVA-1207 program after it failed to meet the…

Read more

Leave a Reply